Expand OCUL Menu
OCUL MENU

OCUL Latest Press Releases

-- December 8, 2025 --

Ocular Therapeutix Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI in Wet AMD Globe Newswire 7:00 AM

-- December 5, 2025 --

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- November 24, 2025 --

Ocular Therapeutix Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI in NPDR Globe Newswire 7:00 AM

-- November 12, 2025 --

Ocular Therapeutix to Participate in November and December Investor Conferences Globe Newswire 7:00 AM

-- November 7, 2025 --

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- November 4, 2025 --

Ocular Therapeutix Reports Third Quarter 2025 Financial Results and Business Highlights Globe Newswire 7:05 AM
Ocular Therapeutix Achieves Target Randomization of 555 Subjects in SOL-R Globe Newswire 7:00 AM

-- October 28, 2025 --

Ocular Therapeutix to Report Third Quarter 2025 Financial Results on November 4, 2025 Globe Newswire 7:00 AM

-- October 7, 2025 --

Ocular Therapeutix to Participate in Upcoming Scientific Conferences Globe Newswire 7:00 AM

-- September 30, 2025 --

Ocular Therapeutix Announces Pricing of Underwritten Offering of Common Stock Globe Newswire 7:08 AM
Ocular Therapeutix Investor Day to Highlight Exceptional AXPAXLI Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary Endpoint Globe Newswire 6:21 AM

-- September 8, 2025 --

Ocular Therapeutix to Host Investor Day on September 30, 2025 Globe Newswire 7:00 AM

-- August 27, 2025 --

Ocular Therapeutix to Participate in September Investor and Scientific Conferences Globe Newswire 7:00 AM

-- August 12, 2025 --

Ocular Therapeutix Receives FDA Agreement Under Special Protocol Assessment (SPA) for Registrational Trial of AXPAXLI in NPDR Globe Newswire 7:00 AM

-- August 5, 2025 --

Ocular Therapeutix Reports Second Quarter 2025 Financial Results and Business Highlights Globe Newswire 7:00 AM

-- July 29, 2025 --

Ocular Therapeutix to Report Second Quarter 2025 Financial Results on August 5, 2025 Globe Newswire 7:00 AM

-- July 22, 2025 --

Ocular Therapeutix to Participate in Upcoming Scientific Conferences Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes